Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr:104:110588.
doi: 10.1016/j.cellsig.2023.110588. Epub 2023 Jan 5.

The signaling pathways activated by ROR1 in cancer

Affiliations
Review

The signaling pathways activated by ROR1 in cancer

María Josefina Quezada et al. Cell Signal. 2023 Apr.

Abstract

The receptor tyrosine kinase orphan receptor 1 (ROR1) is a receptor for WNT5A and related Wnt proteins, that play an important role during embryonic development by regulating cell migration, cell polarity, neural patterning, and organogenesis. ROR1 exerts these functions by transducing signals from the Wnt secreted glycoproteins to the intracellular Wnt/PCP and Wnt/Ca++ pathways. Investigations in adult human cells, particularly cancer cells, have demonstrated that besides these two pathways, the WNT5A/ROR1 axis can activate a number of signaling pathways, including the PI3K/AKT, MAPK, NF-κB, STAT3, and Hippo pathways. Moreover, ROR1 is aberrantly expressed in cancer and was associated with tumor progression and poor survival by promoting cell proliferation, survival, invasion, epithelial to mesenchymal transition, and metastasis. Consequently, numerous therapeutic tools to target ROR1 are currently being evaluated in cancer patients. In this review, we will provide a detailed description of the signaling pathways regulated by ROR1 in cancer and their impact in tumor progression.

Keywords: AKT; MAPK; NF-κB; ROR1; STAT3; Tyrosine kinase; WNT5A; cancer.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors of this paper declare that they have no conflict of interest.

Publication types

MeSH terms

Substances

LinkOut - more resources